Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
OMIM 266130) is a rare autosomal-recessive metabolic disorder characterized by decreased glutathione (GSH) levels owing to defects in glutathione synthetase (GSS)
This phospholipid shell protects the glutathione from the harsh environment of the stomach
SLC7A11 and oxidative stress Oxidative stress is cellular and tissue damage caused by the production of reactive oxygen species (ROS) in the organism exceeding their removal
These include: Intravenous (IV) Injections: As the name suggests, the glutathione injections are administered directly into a vein via an IV drip or IV push
Treatment decisions are made on a case-by-case basis
US$ 22.33
US$ 28.27
US$ 28.80
US$ 21.61
US$ 25.33
US$ 25.77
